Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
JAKKS Pacific Inc is a leisure business based in the US. JAKKS Pacific shares (JAKK) are listed on the NASDAQ and all prices are listed in US Dollars. JAKKS Pacific employs 583 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $12.66 |
|---|---|
| 52-week range | $7.50 - $16.91 |
| 50-day moving average | $13.22 |
| 200-day moving average | $12.21 |
| Wall St. target price | $18.33 |
| PE ratio | 8.6093 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.51 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $12.66 from 2022-06-30
| 1 week (2022-06-23) | 2.18% |
|---|---|
| 1 month (2022-06-02) | -1.25% |
| 3 months (2022-03-30) | -12.63% |
| 6 months (2021-12-31) | 24.61% |
| 1 year (2021-07-02) | 4.63% |
|---|---|
| 2 years (2020-07-02) | 1,513.77% |
| 3 years (2019-07-02) | 1,594.78% |
| 5 years (2017-06-30) | 216.50% |
Valuing JAKKS Pacific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of JAKKS Pacific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
JAKKS Pacific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, JAKKS Pacific shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
JAKKS Pacific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.37. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into JAKKS Pacific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
JAKKS Pacific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $51 million.
The EBITDA is a measure of a JAKKS Pacific's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $658.2 million |
|---|---|
| Operating margin TTM | 6.19% |
| Gross profit TTM | $190.8 million |
| Return on assets TTM | 8.3% |
| Return on equity TTM | 53.74% |
| Profit margin | 2.17% |
| Book value | $5.42 |
| Market capitalisation | $124.6 million |
TTM: trailing 12 months
We're not expecting JAKKS Pacific to pay a dividend over the next 12 months.
JAKKS Pacific's shares were split on a 1:10 basis on 9 July 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your JAKKS Pacific shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for JAKKS Pacific shares which in turn could have impacted JAKKS Pacific's share price.
Over the last 12 months, JAKKS Pacific's shares have ranged in value from as little as $7.5 up to $16.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while JAKKS Pacific's is 2.1765. This would suggest that JAKKS Pacific's shares are significantly more volatile than the average for this exchange and represent a higher risk.
JAKKS Pacific, Inc. develops, produces, markets, sells, and distributes toys, consumables, and electronics and related products worldwide. It operates in two segments, Toys/Consumer Products and Costumes. The company offers action figures and accessories, such as licensed characters; toy vehicles and accessories; dolls and accessories, including small, large, fashion, and baby dolls based on licenses, as well as infant and pre-school products; private label products; and foot-to-floor ride-on products, inflatable environments, tents, and wagons. The company also provides role play, dress-up, pretend play, and novelty products for boys and girls based on brands and entertainment properties, as well as on its own proprietary brands; and indoor and outdoor kids' furniture, activity trays and tables, room décor, kiddie pools, and seasonal and outdoor products. In addition, it offers Halloween and everyday costumes for various ages based on licensed and proprietary non-licensed brands, and related Halloween accessories; outdoor activity toys; and junior sports toys, including hyper-charged balls, sport sets, and toy hoops. The company sells its products through in-house sales staff and independent sales representatives to toy and mass-market retail chain stores, department stores, office supply stores, drug and grocery store chains, club stores, value-oriented dollar stores, toy specialty stores, and wholesalers.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
